BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29451486)

  • 1. [Uveal melanoma, a model disease for splicing alterations and oncogenesis].
    Alsafadi S; Mobuchon L; Rodrigues M; Stern MH
    Med Sci (Paris); 2018 Feb; 34(2):155-160. PubMed ID: 29451486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Uveal Melanoma Metastatic Rate With Stochastic Mutation Rate and Type of Mutation.
    Szalai E; Jiang Y; van Poppelen NM; Jager MJ; de Klein A; Kilic E; Grossniklaus HE
    JAMA Ophthalmol; 2018 Oct; 136(10):1115-1120. PubMed ID: 30073324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SF3B1 and EIF1AX mutations occur in primary leptomeningeal melanocytic neoplasms; yet another similarity to uveal melanomas.
    Küsters-Vandevelde HV; Creytens D; van Engen-van Grunsven AC; Jeunink M; Winnepenninckx V; Groenen PJ; Küsters B; Wesseling P; Blokx WA; Prinsen CF
    Acta Neuropathol Commun; 2016 Jan; 4():5. PubMed ID: 26769193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.
    Decatur CL; Ong E; Garg N; Anbunathan H; Bowcock AM; Field MG; Harbour JW
    JAMA Ophthalmol; 2016 Jul; 134(7):728-33. PubMed ID: 27123562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer.
    Wang XY; Wang Z; Huang JB; Ren XD; Ye D; Zhu WW; Qin LX
    Tumour Biol; 2017 Jun; 39(6):1010428317699111. PubMed ID: 28618948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic signaling in uveal melanoma.
    Park JJ; Diefenbach RJ; Joshua AM; Kefford RF; Carlino MS; Rizos H
    Pigment Cell Melanoma Res; 2018 Nov; 31(6):661-672. PubMed ID: 29738114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic landscape of uveal melanoma.
    Rodrigues MJ; Stern MH
    J Fr Ophtalmol; 2015 Jun; 38(6):522-5. PubMed ID: 25976133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative Copy Number Analysis of Uveal Melanoma Reveals Novel Candidate Genes Involved in Tumorigenesis Including a Tumor Suppressor Role for
    Anbunathan H; Verstraten R; Singh AD; Harbour JW; Bowcock AM
    Clin Cancer Res; 2019 Aug; 25(16):5156-5166. PubMed ID: 31227497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic disease in uveal melanoma: importance of a genetic profile?
    Van Beek JG; Koopmans AE; Vaarwater J; Verdijk RM; de Klein A; Naus NC; Kiliç E
    Melanoma Res; 2015 Oct; 25(5):447-9. PubMed ID: 26086698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma.
    Matatall KA; Agapova OA; Onken MD; Worley LA; Bowcock AM; Harbour JW
    BMC Cancer; 2013 Aug; 13():371. PubMed ID: 23915344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases.
    Yavuzyigitoglu S; Koopmans AE; Verdijk RM; Vaarwater J; Eussen B; van Bodegom A; Paridaens D; Kiliç E; de Klein A;
    Ophthalmology; 2016 May; 123(5):1118-28. PubMed ID: 26923342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-occurrence of BAP1 and SF3B1 mutations in uveal melanoma induces cellular senescence.
    Yu L; Zhou D; Zhang G; Ren Z; Luo X; Liu P; Plouffe SW; Meng Z; Moroishi T; Li Y; Zhang Y; Brown JH; Liu S; Guan KL
    Mol Oncol; 2022 Feb; 16(3):607-629. PubMed ID: 34706158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SF3B1 mutations are associated with alternative splicing in uveal melanoma.
    Furney SJ; Pedersen M; Gentien D; Dumont AG; Rapinat A; Desjardins L; Turajlic S; Piperno-Neumann S; de la Grange P; Roman-Roman S; Stern MH; Marais R
    Cancer Discov; 2013 Oct; 3(10):1122-1129. PubMed ID: 23861464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic genomic and translational efficiency studies of uveal melanoma.
    Johnson CP; Kim IK; Esmaeli B; Amin-Mansour A; Treacy DJ; Carter SL; Hodis E; Wagle N; Seepo S; Yu X; Lane AM; Gragoudas ES; Vazquez F; Nickerson E; Cibulskis K; McKenna A; Gabriel SB; Getz G; Van Allen EM; 't Hoen PAC; Garraway LA; Woodman SE
    PLoS One; 2017; 12(6):e0178189. PubMed ID: 28594900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3.
    Martin M; Maßhöfer L; Temming P; Rahmann S; Metz C; Bornfeld N; van de Nes J; Klein-Hitpass L; Hinnebusch AG; Horsthemke B; Lohmann DR; Zeschnigk M
    Nat Genet; 2013 Aug; 45(8):933-6. PubMed ID: 23793026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and immunohistochemical analyses of uveal melanoma patient cohort.
    Sarubi HC; Pereira NB; Gomes CC; Gomez RS; Carmo ACM; Melo FM; Bastos-Rodrigues L; Pedrosa MS; Friedman E; De Marco L
    Melanoma Res; 2019 Jun; 29(3):248-253. PubMed ID: 30480620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uveal melanoma: Towards a molecular understanding.
    Smit KN; Jager MJ; de Klein A; Kiliҫ E
    Prog Retin Eye Res; 2020 Mar; 75():100800. PubMed ID: 31563544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic, prognostic, and cell-signaling advances in uveal melanoma.
    Harbour JW
    Am Soc Clin Oncol Educ Book; 2013; ():388-91. PubMed ID: 23714557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA HOXA11-AS Exerts Oncogenic Functions by Repressing p21 and miR-124 in Uveal Melanoma.
    Lu Q; Zhao N; Zha G; Wang H; Tong Q; Xin S
    DNA Cell Biol; 2017 Oct; 36(10):837-844. PubMed ID: 28749709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transposase mapping identifies the genomic targets of BAP1 in uveal melanoma.
    Yen M; Qi Z; Chen X; Cooper JA; Mitra RD; Onken MD
    BMC Med Genomics; 2018 Nov; 11(1):97. PubMed ID: 30400891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.